Capital Raising: The Bridge Financing Test

Capital raising can buy time without improving the business that needs it. A bridge round has a stronger case when it pays for evidence a new investor needs. It can also consume the remaining cash while everyone waits for a friendlier market. Canada's latest venture figures make the distinction worth examining, provided you read past the headline percentage.

On 20 October, CPE Media reported that bridge financing accounted for C$1.07 billion, or 23% of Canadian venture funding in the first nine months of 2026. Its comparison was 9% in 2025.[1] That looks like a market buying more time. The detail is less tidy, and more useful for anyone preparing a funding proposal.

Read the bridge-financing figure before borrowing the story

The same release flags Cohere's C$677.2 million SAFE bridge financing and says the investors have not been publicly identified. CPE warns that the missing information could materially affect portions of its report.[1] On those figures, that one financing is equivalent to roughly 63% of the reported bridge total. Treat that as a comparison of disclosed sizes, not a finding about the financial health of every Canadian startup.

A large share of dollars does not establish a large share of companies. Nor does the word bridge tell you whether a business is funding an imminent commercial milestone, postponing a valuation negotiation or dealing with a cash shortfall. You need the transaction terms and the operating plan to make that judgement. The category alone cannot carry it.

CPE also reports that growth- and later-stage companies attracted C$488 million, representing 10% of funding, against 37% in 2025.[1] These are Canadian figures, not an Australian funding forecast. The 2026 period covers nine months; the release labels its comparison as 2025. Keep those boundaries intact rather than turning the numbers into a universal claim that the next round has disappeared.

For a founder reading this from Australia, the useful response is to examine what the next investor would need to see. A market statistic can explain the backdrop to that conversation. It cannot establish that your customers will renew or that your prospective lead investor has money available to commit.

Finance a change in the evidence

Consider a hypothetical software company waiting for a large customer to move from pilot to paid deployment. A bridge could fund the implementation work and enough operating time to collect the first payments. That is a specific proposition: spend this money, complete this work, then show an investor a paying deployment rather than a promising trial.

The proposal weakens if the company calls a signed pilot the milestone while budgeting as though the full contract is already cash. Put the customer's acceptance conditions beside the spending plan. Identify what still requires the customer's approval and when payment becomes due. A commercial promise with unfinished implementation is different from money available to meet payroll.

The same discipline applies to infrastructure. A proposed facility with an unresolved power connection has a different financing problem from one with contracted supply. Our earlier piece on AI infrastructure's power procurement bottleneck examines that operating constraint. For a bridge proposal, name the document or completed work that would change the financing case, and identify who can actually deliver it.

I would want that evidence stated before the round size. More cash is useful when it lets the team finish work that changes a buyer's or investor's decision. Funding another stretch of the same untested assumptions is a much weaker case, even if the cheque preserves the last valuation on paper.

Runway must include the next funding process

Build the cash plan through the milestone and the financing process that follows it. Reaching a product release on the day the bank balance runs out does not leave much room for an investor to investigate the result. Show the expected spending while a prospective lead reviews the evidence and negotiates the proposed investment.

Use a weekly cash forecast where timing is tight. Separate receipts already due from sales that still need to close. Put material commitments on their actual payment dates. A monthly average can hide a payment falling before the customer receipt intended to cover it. The point is to expose the period in which the company would need a decision, rather than celebrate an attractive runway number.

Then delay the critical event in the model. In the hypothetical software case, move customer acceptance back and let the related cash receipt move with it. Record what spending could stop, what the team would still owe and how much time remains to pursue another option. This is a planning exercise, not a claim that every customer will pay late.

The alternative should be executable while the business still has cash. A smaller deployment or a narrower product scope may preserve useful evidence at lower cost. Write down who can approve that change and when the team would make the call. An alternative requiring the same investor approval as the original plan offers little protection against that investor declining.

Examine the terms beyond the announced valuation

Ask the company's advisers to model the proposed instrument against its existing capital structure. Have them show the ownership outcome under a plausible next round and explain which provisions change that outcome. Do not infer the economics of a particular SAFE, convertible instrument or equity round from its label. The signed documents govern the proposal.

Include existing investors' participation in that discussion without treating it as an automatic endorsement. Establish what each investor has actually committed, what remains conditional and whether there is a lead prepared to finance the next stage. A supportive conversation is useful. It should not appear as an unconditional receipt in the cash forecast.

Keep company funding separate from shareholder liquidity, too. CPE's methodology includes equity and quasi-equity invested directly into companies but excludes secondary transactions where no capital flows to the company.[1] That distinction matters when reading any announced transaction total: money paid to a selling holder cannot also be counted as cash funding the operating plan.

Before taking a bridge proposal to investors, prepare one page linking the requested cash to a dated piece of evidence. Attach the forecast through the next funding decision and the actions available if the milestone slips. Someone outside the business should be able to follow that sequence without accepting the founder's confidence as an input.

Canada's report gives us a concentrated bridge-financing figure with an explicit information gap, not a diagnosis of every company in the market.[1] The practical lesson for capital raising is narrower. Judge the proposed round by the work it funds and the options left afterwards. Extra time has value when the company can show what it intends to change before that time runs out.